Phillips-Medisize said today that it plans to open an 80,000 square foot drug delivery manufacturing facility at its Menomonie, Wisconsin campus. The facility, which is expected to open in 2017, will manufacture high volume, prefilled drug delivery systems. It will employ at least 100 people, the company said, and is funded by the signing of a new supply contract with an undisclosed biopharmaceutical company.
The site’s expansion is the latest in a series over the past 4 years. Last November, Phillips-Medisize doubled the size of its New Richmond, Wisconsin medical device facility and earlier this year, the company opened a 17,000 square foot clinical and pilot build facility for drug delivery combination products in Menomonie, Wisconsin.
Get the full story at our sister site, Drug Delivery Business News.
The post Phillips-Medisize to build drug delivery manufacturing facility in Wisconsin appeared first on MassDevice.